Skip to main content

Main menu

  • HOME
  • ARTICLES
    • Current Issue
    • Ahead of Print
    • Archives
    • Abstracts In Press
    • Special Issue Archive
    • Subject Collections
  • INFO FOR
    • Authors
    • Reviewers
    • Call For Papers
    • Subscribers
    • Advertisers
  • SUBMIT
    • Manuscript
    • Peer Review
  • ABOUT
    • The JABFM
    • The Editing Fellowship
    • Editorial Board
    • Indexing
    • Editors' Blog
  • CLASSIFIEDS
  • Other Publications
    • abfm

User menu

Search

  • Advanced search
American Board of Family Medicine
  • Other Publications
    • abfm
American Board of Family Medicine

American Board of Family Medicine

Advanced Search

  • HOME
  • ARTICLES
    • Current Issue
    • Ahead of Print
    • Archives
    • Abstracts In Press
    • Special Issue Archive
    • Subject Collections
  • INFO FOR
    • Authors
    • Reviewers
    • Call For Papers
    • Subscribers
    • Advertisers
  • SUBMIT
    • Manuscript
    • Peer Review
  • ABOUT
    • The JABFM
    • The Editing Fellowship
    • Editorial Board
    • Indexing
    • Editors' Blog
  • CLASSIFIEDS
  • JABFM on Bluesky
  • JABFM On Facebook
  • JABFM On Twitter
  • JABFM On YouTube
Review ArticleClinical Review

Abuse of Prescription and Over-the-Counter Medications

James E. Lessenger and Steven D. Feinberg
The Journal of the American Board of Family Medicine January 2008, 21 (1) 45-54; DOI: https://doi.org/10.3122/jabfm.2008.01.070071
James E. Lessenger
private practice, Benicia, California (JEL)
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Steven D. Feinberg
Department of Orthopaedic Surgery-Physical and Rehabilitative Medicine, Stanford University School of Medicine, California (SDF)
MD, MPH
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Supplemental
  • References
  • Info & Metrics
  • PDF
Loading

References

  1. ↵
    DuPont RL. Prescription stimulant abuse. Psychiatr Ann 2005; 35: 93–7.
    OpenUrl
  2. ↵
    Collins GB, McAllister MS. Combating abuse and diversion of prescription opiate medications. Psychiatr Ann 2006; 36: 410–6.
    OpenUrl
  3. ↵
    Substance Abuse and Mental Health Services Administration. Results from the 2005 National Survey on Drug Use and Health: national findings. Rockville (MD): Office of Applied Studies, NSDUH Series H-30, DHHS Publication no. 2006;SMA 06–4194.
  4. ↵
    Center for Disease Control and Prevention. Unintentional deaths from drug poisoning by urbanization of area: New Mexico, 1994–2003. MJWR 2005; 54: 870–3.
    OpenUrl
  5. ↵
    National Survey on Drug Use and Health. Non-medical use of prescription pain relievers. Washington, DC: Office of Applied Studies, Substance Abuse and Mental Health Services Administration; 2004.
  6. ↵
    Lessenger JE, Lessenger LH, Lessenger EW. An outcome analysis of Drug Court in Tulare County, California. Visalia (CA): Tulare County Superior Court; 2000.
  7. ↵
    National Survey on Drug Use and Health. Characteristics of primary prescription and OTC treatment admissions: 2002. Washington, DC: Office of Applied Studies, Substance Abuse and Mental Health Services Administration; 2004.
  8. ↵
    Drug Abuse Warning Network. Emergency department visits involving non-medical use of selected pharmaceuticals. Washington, DC: Office of Applied Studies, Substance Abuse and Mental Health Services Administration; 2006.
  9. ↵
    Miller WR, Baca C, Compton WM, et al. Addressing substance abuse in health care settings. Alcohol Clin Exp Res 2006; 30: 292–302.
    OpenUrlCrossRefPubMedWeb of Science
  10. ↵
    Goodman FDC, Glassman P. Evaluating potentially aberrant outpatient prescriptions for extended-release oxycodone. Am J Health Syst Pharm 2005; 62: 2604–8.
    OpenUrlFREE Full Text
  11. ↵
    National Household Survey on Drug Abuse. Non-medical use of prescription-type drugs among youths and young adults. Washington, DC: Office of Applied Studies, Substance Abuse and Mental Health Services Administration; 2003.
  12. ↵
    Drug Abuse Warning Network. Emergency department visits involving ADHD stimulant medications. Washington, DC: Office of Applied Studies, Substance Abuse and Mental Health Services Administration; 2006.
  13. ↵
    Miller NS. Physicians and the controlled substance laws for opiate prescription medications. Psychiatr Ann 2006; 36: 422–9.
    OpenUrl
  14. ↵
    Weaver M, Schnoll S. Abuse liability in opioid therapy for pain treatment in patients with an addiction history. Clin J Pain 2002; 18: S61–9.
    OpenUrlCrossRefPubMedWeb of Science
  15. ↵
    London M. Prevention of substance abuse. Curr Opin Psychiatry 2001; 14: 207–11.
    OpenUrl
  16. ↵
    Gilson AM, Ryan KM, Joranson DE, Dahl JL. A reassessment of trends in the medical use and abuse of opioid analgesics and implications for diversion control: 1997–2002. J Pain Symptom Manage 2004; 28: 176–88.
    OpenUrlCrossRefPubMedWeb of Science
  17. ↵
    National Institute on Drug Abuse. Prescription drug abuse chart. Washington, DC: National Institute on Drug Abuse; 2006.
  18. ↵
    The National Center on Addiction and Substance Abuse at Columbia University. You’ve got drugs: prescription drug pushers on the internet: 2006 update. New York: The National Center on Addiction and Substance Abuse at Columbia University; 2006.
  19. ↵
    Carter LP, Richards BD, Mintzer MZ, Griffiths RR. Relative abuse liability of GHB in humans: a comparison of psychomotor, subjective, and cognitive effects of supratherapeutic doses of triazolam, pentobarbital, and GHB. Neuropsychopharmacology 2006; 31: 2537–51.
    OpenUrlCrossRefPubMedWeb of Science
  20. ↵
    Trescott AM, Boswell MV, Atluri SL, et al. Opioid guidelines in the management of chronic non-cancer pain. Pain Physician 2006; 9: 1–40.
    OpenUrlPubMed
  21. ↵
    Bewley T, Ghodse AH. Unacceptable face of private practice: prescription of controlled drugs to addicts. BMJ 1983; 286: 1876–7.
    OpenUrlAbstract/FREE Full Text
  22. ↵
    Longo L, Johnson B. Addiction: part I. Benzodiazepines: side effects, abuse risk and alternatives. Am Fam Physician 2000; 61: 2121–8.
    OpenUrlPubMedWeb of Science
  23. ↵
    Reeves RR, Carter OS, Pinkofsky HB, Struve FA, Bennett DM. Carisoprodol (Soma): abuse potential and physician unawareness. J Addict Dis 1999; 18: 51–6.
    OpenUrlCrossRefPubMed
  24. ↵
    Fisher DG, Malow R, Rosenberg R, Reynolds GL, Farrell N, Jaffe A. Recreational Viagra use and sexual risk among drug abusing men. Am J Infect Dis 2006; 2: 107–14.
    OpenUrlPubMed
  25. ↵
    Musacchio NS, Hartrich M, Garofalo E. Erectile dysfunction and Viagra use: what's up with college-age males? J Adolesc Health 2006; 39: 452–4.
    OpenUrlPubMed
  26. ↵
    McCambridge J, Mitcheson L, Hunt N, Winstock A. The rise of Viagra among British illicit drugs uses: 5-year survey data. Drug Alcohol Rev 2006; 25: 111–3.
    OpenUrlCrossRefPubMedWeb of Science
  27. ↵
    Fernandez MI, Perrino T, Collazo JB, et al. Surging new territory: club-drug use and risky sex among Hispanic men who have sex with men recruited on the Internet. J Urban Health 2005; 82(1 Suppl 1): i79–88. Epub 2005 Feb 28.
    OpenUrl
  28. ↵
    Mansergh G, Shouse RL, Marks G, et al. Methamphetamine and sildenafil (Viagra) use are linked to unprotected receptive and insertive anal sex, respectively, in a sample of men who have sex with men. Sex Transm Infect 2006; 82: 131–4.
    OpenUrlAbstract/FREE Full Text
  29. ↵
    Paul JP, Pollack L, Osmond D, Catania JA. Viagra (sildenafil) use in a population-based sample of U.S. men who have sex with men. Sex Transm Dis 2005; 32: 531–3.
    OpenUrlCrossRefPubMedWeb of Science
  30. ↵
    Purcell Dw, Wolitski RJ, Hoff CC, Parsons JT, Woods WJ, Halkitis PN. Predictors of the use of Viagra, testosterone, and antidepressants among HIV-seropositive gay and bisexual men. AIDS 2005; 19(suppl 1): S57–66.
    OpenUrl
  31. ↵
    Copeland J, Dillon P, Gascoigne M. Ecstasy and the concomitant use of pharmaceuticals. Addict Behav 2006; 31: 367–70.
    OpenUrlCrossRefPubMed
  32. ↵
    Abbot FV, Fraser MI. Use and abuse of over-the-counter analgesic agents. J Psychiatry Neurosci 1998; 23: 13–34.
    OpenUrlPubMedWeb of Science
  33. ↵
    Kanayama G, Gruber AJ, Pope HG, Borowieckii JJ, Hudson JI. Over-the-counter drug use in gymnasiums: an under-recognized substance abuse problem? Psychother Psychosom 2001; 70: 137–40.
    OpenUrlCrossRefPubMedWeb of Science
  34. ↵
    National Institute on Drug Abuse. Hallucinogens and dissociative drugs. Washington, DC: National Institute on Drug Abuse; 2006.
  35. ↵
    Schwartz RH. Adolescent abuse of dextromethorphan. Clin Pediatr (Phila) 2005; 44: 565–8.
    OpenUrlAbstract/FREE Full Text
  36. ↵
    Miller SC. Dextromethorphan psychosis, dependence and physical withdrawal. Addict Biol 2005; 10: 325–7.
    OpenUrlCrossRefPubMedWeb of Science
  37. ↵
    Desai S, Aldea D, Daneels E, Soliman M, Braksmajer AS, Kopes-Kerr CP. Chronic addiction to dextromethorphan cough syrup: a case report. J Am Board Fam Med 2006; 19: 320–3.
    OpenUrlAbstract/FREE Full Text
  38. ↵
    Baker SD, Borys DJ. A possible trend suggesting increased abuse from Coricidin exposures reported to the Texas Poison Network: comprising 1998 to 1999. Vet Hum Toxicol 2002; 44: 169–71.
    OpenUrlPubMedWeb of Science
  39. ↵
    Austin H, Monasterio E. Acute psychosis following ingestion of “Rapture.” Australas Psychiatry 2004; 12: 406–8.
    OpenUrlAbstract/FREE Full Text
  40. ↵
    Halpert AG, Olmstead MC, Beninger RJ. Mechanisms and abuse liability of the anti-histamine dimenhydrinate. Neurosci Biobehav Rev 2002; 26: 61–7.
    OpenUrlCrossRefPubMedWeb of Science
  41. ↵
    Griffiths RR, Johnson MW. Relative abuse liability of hypnotic drugs: a conceptual framework and algorithm for differentiating among compounds. J Clin Psychiatry 2005; 66: 31–41.
    OpenUrlPubMedWeb of Science
  42. ↵
    Pragst F, Herre S, Bakdash A. Poisonings with diphenhydramine: a survey of 68 clinical and 55 death cases. Forensic Sci Int 2006; 161: 189–97.
    OpenUrlCrossRefPubMedWeb of Science
  43. ↵
    Nigro SA. Toxic psychosis due to diphenhydramine hydrochloride. JAMA 1968; 203: 301–2.
    OpenUrlCrossRefPubMed
  44. ↵
    Kockler DR, McCarthy MW, Lawson CL. Seizure activity and unresponsiveness after Hydrocut ingestion. Pharmacotherapy 2001; 21: 647–51.
    OpenUrlCrossRefPubMedWeb of Science
  45. Bassett KE, Schunk JE, Crouch BI. Cyclizine abuse by teenagers in Utah. Am J Emerg Med 1996; 14: 472–4.
    OpenUrlCrossRefPubMedWeb of Science
  46. ↵
    Hall AH, Kulig KW, Rumack BH. Intravenous epinephrine abuse. Am J Emerg Med 1987; 5: 64–5.
    OpenUrlPubMed
PreviousNext
Back to top

In this issue

The Journal of the American Board of Family Medicine: 21 (1)
The Journal of the American Board of Family Medicine
Vol. 21, Issue 1
January-February 2008
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on American Board of Family Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Abuse of Prescription and Over-the-Counter Medications
(Your Name) has sent you a message from American Board of Family Medicine
(Your Name) thought you would like to see the American Board of Family Medicine web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
3 + 1 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
Abuse of Prescription and Over-the-Counter Medications
James E. Lessenger, Steven D. Feinberg
The Journal of the American Board of Family Medicine Jan 2008, 21 (1) 45-54; DOI: 10.3122/jabfm.2008.01.070071

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Abuse of Prescription and Over-the-Counter Medications
James E. Lessenger, Steven D. Feinberg
The Journal of the American Board of Family Medicine Jan 2008, 21 (1) 45-54; DOI: 10.3122/jabfm.2008.01.070071
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Scope of the Problem
    • Trends in Use
    • Abused OTC Drugs
    • Strategies for Physicians
    • Notes
    • References
  • Figures & Data
  • Supplemental
  • References
  • Info & Metrics
  • PDF

Related Articles

  • Correction to “Abuse of Prescription and Over-the-Counter Medications”
  • PubMed
  • Google Scholar

Cited By...

  • Content Usage and the Most Frequently Read Articles in 2009
  • Introduction of More Editorial Board Members and the Most Frequently Read Articles in 2008
  • North American Primary Care Research Group President's Award
  • Google Scholar

More in this TOC Section

  • Interpretating Normal Values and Reference Ranges for Laboratory Tests
  • Non-Surgical Management of Urinary Incontinence
  • Screening and Diagnosis of Type 2 Diabetes in Sickle Cell Disease
Show more Clinical Reviews

Similar Articles

Navigate

  • Home
  • Current Issue
  • Past Issues

Authors & Reviewers

  • Info For Authors
  • Info For Reviewers
  • Submit A Manuscript/Review

Other Services

  • Get Email Alerts
  • Classifieds
  • Reprints and Permissions

Other Resources

  • Forms
  • Contact Us
  • ABFM News

© 2025 American Board of Family Medicine

Powered by HighWire